You’ll be equipped to support individuals through preparation, integration, and harm-reduction-informed care related to psychedelic experiences, within your professional scope.
This training also helps professionals navigate Canada’s evolving legal frameworks, including programs like the Special Access Program (SAP), clinical trials, and Section 56 exemptions, while advocating for safe, ethical, and compassionate access.
While it does not itself authorize the clinical provision of psychedelics, it builds a strong foundation for professionals working at the forefront of psychedelic care, research, and policy change.
